BioSpace News Archive

PureTech Founded Entity Akili Named to Fast Company ’s Annual List of the World’s 50 Most Innovative Companies for 2022.

LumaCyte Corporation announced the successful completion of an A round financing that will allow the company to accelerate its global expansion efforts and service the increasing global demand of its flagship product, Radiance ®.

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, has been recognized on Fast Company’s annual list of the World’s Most Innovative Companies for 2022.

Aptose Biosciences Inc. will report financial results for the year and quarter ended December 31, 2021, on Tuesday, March 22, 2022 after the close of the market, and provide a corporate update.

Organogenesis Holdings Inc. announced that company management will participate in Oppenheimer’s 32nd Annual Healthcare Conference, which is being held virtually from March 15th-16th.

XOMA Corporation, a biotech royalty aggregator playing a distinctive role in helping companies achieve their goal of improving human health, reported its 2021 financial results and provided a recent operations update.

Neuronetics, Inc. announced its financial and operating results for the fourth quarter and full year of 2021.

InspireMD, Inc., developer of the CGuard™ Embolic Prevention System for the prevention of stroke caused by the treatment of Carotid Artery Disease, announced financial and operating results for the fourth quarter and year ended December 31, 2021.

InMed Pharmaceuticals Inc. announces that Eric A. Adams, InMed’s President and Chief Executive Officer, will be presenting at the 34th Annual Roth Conference being held March 13-15, 2022.

BridgeBio Pharma, Inc. and Sentynl Therapeutics, Inc., a U.S.-based biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases owned by Zydus Lifesciences Ltd., announced the execution of an asset purchase agreement for the sale of BridgeBio’s NULIBRY™ for Injection.